WallStreetZenWallStreetZen

NASDAQ: KZIA
Kazia Therapeutics Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

KZIA past revenue growth

How has KZIA's revenue growth performed historically?
Company
1,041.43%
Industry
144.63%
Market
17.55%
KZIA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KZIA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KZIA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KZIA earnings and revenue history

Current Revenue
$15.6k
Current Earnings
-$10.7M
Current Profit Margin
-68,256.8%

KZIA Return on Equity

Current Company
-186.4%
Current Industry
-63.5%
Current Market
188%
KZIA's Return on Equity (-186.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KZIA announces earnings.

KZIA Return on Assets

Current Company
-60.1%
Current Industry
2.9%
KZIA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KZIA Return on Capital Employed

Current Company
-122.43%
Current Industry
19.5%
KZIA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KZIA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KZIA$15.13kN/A-$10.33M-65.97%N/A
PPBT$0.00$22.27M$19.88M-100.00%N/A
ERNA$68.00k-$19.93M-$21.68M-68.89%N/A
AEZS$4.50M-$16.38M-$16.55M-30.06%N/A
ONVO$242.00k-$18.82M-$19.09M-41.45%N/A
View Top Biotech Stocks

Kazia Therapeutics Earnings & Revenue FAQ

What were KZIA's earnings last quarter?

On Invalid Date, Kazia Therapeutics (NASDAQ: KZIA) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Kazia Therapeutics earnings for the quarter were N/A. In the same quarter last year, Kazia Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Kazia Therapeutics stock.

What was KZIA's earnings growth in the past year?

As of Q2 2024, Kazia Therapeutics's earnings has grown year over year. Kazia Therapeutics's earnings in the past year totalled -$10.33 million.

What was KZIA's revenue last quarter?

On Invalid Date, Kazia Therapeutics (NASDAQ: KZIA) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Kazia Therapeutics's revenue was N/A.

What was KZIA's revenue growth in the past year?

As of Q2 2024, Kazia Therapeutics's revenue has grown 1,041.43% year over year. This is 896.8 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Kazia Therapeutics's revenue in the past year totalled $15.13 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.